TransIT-AAViator Transfection System (1.5 L Cuture)
Stop compromising between AAV titer, quality, and cost. Manufacturing high-yield, high-quality adeno-associated virus for gene therapy presents significant challenges, from low particle yield and high percentages of empty capsids to the prohibitive cost of GMP-grade plasmid DNA.